The third dose of mRNA SARS-CoV-2 vaccines enhances the spike-specific antibody and memory B cell response in myelofibrosis patients

Vaccination against SARS-CoV-2 using mRNA-based vaccines has been highly recommended for fragile subjects, including myelofibrosis patients (MF). Available data on the immune responsiveness of MF patients to mRNA SARS-CoV-2 vaccination, and the impact of the therapy with the JAK inhibitor ruxolitini...

Descripción completa

Detalles Bibliográficos
Autores principales: Fiorino, Fabio, Ciabattini, Annalisa, Sicuranza, Anna, Pastore, Gabiria, Santoni, Adele, Simoncelli, Martina, Polvere, Jacopo, Galimberti, Sara, Baratè, Claudia, Sammartano, Vincenzo, Montagnani, Francesca, Bocchia, Monica, Medaglini, Donata
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9556722/
https://www.ncbi.nlm.nih.gov/pubmed/36248803
http://dx.doi.org/10.3389/fimmu.2022.1017863

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9556722/
https://www.ncbi.nlm.nih.gov/pubmed/36248803
http://dx.doi.org/10.3389/fimmu.2022.1017863

Ejemplares similares